Saphenous vein grafts, along with the left internal thoracic artery graft, are the hallmark of
coronary artery bypass grafting (CABG). Grounded on vast and landmark evidence, this …

Myocardial ischaemia resulting from obstructive coronary artery disease is a major cause of
morbidity and mortality in the developed world. Coronary artery bypass graft (CABG) surgery …

Ischemic heart disease is currently the leading cause of death globally, with coronary artery
bypass grafting among the most common operations performed worldwide. More extensive …

Introduction: There have been several attempts to overcome the poor graft patency of
saphenous vein grafts.“No-touch” saphenous vein graft (NT-SVG) could be a solution to …

The SWEDEGRAFT study (ClinicalTrials. gov Identifier: NCT03501303) tests the hypothesis
that saphenous vein grafts (SVGs) harvested with the “no-touch” technique improves …

Objectives This study investigates whether the no-touch (NT) vein graft, at a mean time of 16
years, maintains a significantly higher patency rate than conventional (C) vein grafts and still …

The saphenous vein is the most common conduit used in coronary artery bypass grafting
(CABG) yet its failure rate is higher compared to arterial grafts. An improvement in …

With more than 800,000 coronary artery bypass grafting (CABG) operations annually
worldwide and the saphenous vein being the most common conduit used, there is no …

For many reasons, the saphenous vein (SV) and internal thoracic artery (ITA) will continue to
be the most important conduits in coronary artery bypass grafting (CABG). The high …

Introduction: This single-center study of propensity-matched data was performed to assess
the effect of the no-touch saphenous vein (NTSV) harvesting technique on early-and long …